Stockreport

Identity and Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M; Investor Call Tomorrow at 10...

BIO-key International, Inc.  (BKYI) 
NASDAQ:AMEX Investor Relations: bio-key.com/investors
PDF featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced preliminary results for its fourth quarter (Q4'23) and year end [Read more]